<DOC>
	<DOCNO>NCT01001585</DOCNO>
	<brief_summary>Summary . At present , investigator perfect anesthetic mitochondrial patient . When possible , consideration give use local anesthetic small amount . When general anesthetic necessary , carry significant risk associate poor outcome . At present possible eliminate one group le safe others . What clear patient must monitor closely patient . The advent bispectral index ( BIS ) monitor may allow u monitor depth anesthesia closely thus expose patient minimum amount drug necessary carry surgical procedure . Purpose . The investigator hypothesize specific mitochondrial disease , particular decrease complex I function , make certain child hypersensitive volatile anesthetic . These patient may increase risk adverse outcome follow general anesthesia . The specific aim application : 1 . Determine molecular defect mitochondrial function lead alter sensitivity VA sevoflurane . 2 . Establish relative safety sevoflurane treatment patient mitochondrial disease . The investigator plan monitor patient mitochondrial disease use expanded measure cardiovascular stability measurement brain electrical activity slowly induce general anesthesia . The investigator use measurement limit amount anesthetic patient receive attempt minimize risk . In addition , investigator correlate sensitivity type mitochondrial defect investigator may able predict patient likely increased sensitivity .</brief_summary>
	<brief_title>Anesthetic Effects Mitochondrial Disease</brief_title>
	<detailed_description />
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Patients present operating room muscle biopsy part diagnostic workup possible mitochondrial disease . Patients 16 year age . Patients concurrent acute infectious disease . Patients tolerate slow induction emotional reason . Initial BIS measurement less 95 . Documented pulmonary disease .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>mitochondrial disease</keyword>
	<keyword>sevoflurane</keyword>
	<keyword>mitochondrial disease sevoflurane sensitivity</keyword>
</DOC>